FOllow-up of LOW-acuity Patients After REdirection From a Swiss Emergency Department Using an Electronic TRIage Application

NCT ID: NCT06971419

Last Updated: 2025-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-15

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Emergency department (ED) overcrowding is a growing issue, affecting patient safety, healthcare quality, and hospital efficiency. One strategy to manage low-acuity patients is triage-based redirection, where patients with non-urgent conditions are offered the option to receive care at external medical facilities instead of the ED.

This monocentric, prospective observational study will be conducted at Fribourg Cantonal Hospital, Switzerland, and evaluates the impact of a new electronic triage and redirection system (Logibec Réorientation). The study compares two triage processes:

Current practice - Redirection based on the Swiss Emergency Triage Scale (SETS), limited to low-acuity patients (SETS 4).

New practice - Redirection using the Logibec software, allowing redirection of both low-acuity (SETS 4) and semi-urgent (SETS 3) patients based on predefined criteria.

The primary objective is to assess whether the new triage-based redirection reduces the number of ED consultations per patient within 48 hours of their initial visit.

Secondary outcomes include:

Number of consultations in the ED or other medical facilities within 7 days Rate of hospital admissions within 7 days Patient satisfaction with redirection Evolution of health literacy over 6 months Number of ED visits over 6 months Participants are adult patients (≥18 years old) classified as SETS 3-4 and identified as eligible for redirection by the Logibec software. Data will be collected through phone interviews and questionnaires over a 6-month follow-up period.

This study aims to improve triage efficiency, patient flow management, and healthcare accessibility, while ensuring patient safety in the redirection process.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Triage Low Acuity Patients Health Literacy Level Non-urgent Emergencies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comparator Group (Current Practice - SETS-Based Triage and Redirection)

* Patients are triaged using the Swiss Emergency Triage Scale (SETS)
* Only low-acuity patients (SETS 4) are considered for redirection
* Patients who agree to redirection are referred to external medical facilities (e.g., primary care clinics)

No interventions assigned to this group

Investigated Group (New Practice - Logibec-Assisted Triage and Redirection)

* Patients tiraged as SETS 4 and SETS 3 are further evaluated by Logibec Réorientation software which applies applies specific inclusion/exclusion criteria to determine eligibility for redirection
* Eligible patients are offered redirection, with appointments scheduled through the Reorientation software by the triage nurse

intervention is the use of aTriage-Based Patient Redirection Using an Electronic Decision Support Toolin the emergency department (ED)

Intervention Type OTHER

Name: Logibec Réorientation software-assisted triage and redirection

Type: Decision support system for emergency triage

Implementation:

* Applied during patient triage in the emergency department
* Assists in identifying low-acuity (SETS 4) and semi-urgent (SETS 3) patients eligible for redirection
* Uses standardized inclusion/exclusion criteria to guide redirection decisions

Comparator: Standard nurse-led triage and redirection based only on the Swiss Emergency Triage Scale (SETS)

Key Distinction:

* The investigated group receives Logibec-assisted triage and redirection.
* The comparator group follows traditional nurse-led triage without electronic support, limiting redirection to SETS 4 patients only.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intervention is the use of aTriage-Based Patient Redirection Using an Electronic Decision Support Toolin the emergency department (ED)

Name: Logibec Réorientation software-assisted triage and redirection

Type: Decision support system for emergency triage

Implementation:

* Applied during patient triage in the emergency department
* Assists in identifying low-acuity (SETS 4) and semi-urgent (SETS 3) patients eligible for redirection
* Uses standardized inclusion/exclusion criteria to guide redirection decisions

Comparator: Standard nurse-led triage and redirection based only on the Swiss Emergency Triage Scale (SETS)

Key Distinction:

* The investigated group receives Logibec-assisted triage and redirection.
* The comparator group follows traditional nurse-led triage without electronic support, limiting redirection to SETS 4 patients only.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years old
* Triage level SETS 3 or SETS 4 (classified as semi-urgent or low-acuity)
* Identified as eligible for redirection by the Logibec electronic triage system
* Able to speak and read French or German (for informed consent and follow-up)
* Provides informed consent: Oral consent at Day 2 and Signed informed consent sent by post after inclusion

Exclusion Criteria

* Inability to provide informed consent (e.g., cognitive impairment, language barrier without translation support)
* Inability to comply with study procedures, such as: Severe hearing impairment without hearing aids; Acute psychiatric conditions preventing participation; Not available for follow-up phone calls within the next 6 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Fribourg

OTHER

Sponsor Role collaborator

Hôpital Fribourgeois

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vincent Ribordy, Prof.

Role: STUDY_DIRECTOR

HFR-Fribourg Emergency Department, University of Fribourg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HFR-Fribourg

Fribourg, Canton of Fribourg, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Youcef Guechi, MD

Role: CONTACT

+41263063112

Ludovic Galofaro, MD

Role: CONTACT

+41263063112

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Youcef Guechi, MD

Role: primary

+41263063060

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HFR_24-09

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2023-01655

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.